HIV/AIDS

Nearly a quarter of HIV positive patients getting care through the Ryan White federally funded treatment program have not gotten their viral loads down. The analysis was made by the district's health department, which has used the data to address the problem.

Can Pre-Exposure Prophylaxis for HIV be given post-exposure? Absolutely, a New York City team reports.

When a non-profit AIDS advocacy group offers as many programs as Gay Men's Health Crisis (GMHC) efficiency is a challenge. The organization relies on three management practices to remain efficient and audit-ready, particularly data-driven administrative supervision.

HIV AIDS is treatable but in rural areas the fear of people finding out an individual's HIV status can be a barrier. A University of Virginia Health System team has had success with training peer coaches to counsel such patients.

San Francisco, CA, with the backing of generous state Medicaid coverage, believes it can wipe out hepatitis C in vulnerable populations including people with HIV, intravenous drug users, homeless people, and prisoners in the city's jails.

HIV/AODS research has tended to silo people into particular categories or particular communities like injecting drug users, men who have sex with men, etc.

More than 40% of US AIDS/HIV cases are in San Juan, Puerto Rico, but economic turmoil there is making it hard to fight the epidemic.

For 30 years, an outreach group in Oakland, CA has been winning the confidence of prostitutes as the first step in helping them be healthy and HIV-free. California Prostitutes Education Project representatives offered tips in a workshop.

Bonus video: As the 20th Annual US Conference on AIDS wound down, one presenter stood out—not just for advocacy work. She also sings. Here’s the conclusion of our interview with Adriana Garriga-Lopez, PhD, singing Manuel de Falla's "Nana".

Experts need to think about public health in a smarter way; it shouldn't just be about emergency management.

When talking about HIV, you're not just talking about one thing; you're talking about many different epidemics.

Exploring the HIV/AIDS epidemic in Puerto Rico, Adriana Garriga-Lopez, PhD, questioned how colonialism manifests on an every day level.

A high percentage of people with HIV are also cigarette smokers, a problem that the state of Michigan is tackling with targeting smoking cessation programs.

The fight against HIV is not just a fight against a virus.

"It's great that we have more tools for HIV prevention, but we should also work on the conditions that put people at risk."

Despite the development in HIV/ADIS research, "We are not close to where we should be or where we'd like to be," shared Carlos Rodriguez Diaz, PhD, University of Puerto Rico.

WIth high rates of HIV infection among black and Latino men who have sex with men, a dozen cities in the US have started trial programs aimed at getting HIV negative MSM to embrace pre-exposure prophylaxis, both "holistic" and pharmaceutical.

Ending this epidemic isn't just about stopping HIV, it's about really giving value and respect to sexual health and sexual well being.

HIV isn't just an issue of health or public health; rather, HIV is a magnifying glass to a myriad of social justice and human rights challenges that will not go away even if we end HIV.

“Although the etiology of multiple sclerosis (MS) remains elusive, it is clear that Epstein Barr Virus (EBV) and possibly other viruses have a role in the pathogenesis of MS,” researchers started a presentation at ECTRIMS 2016 in London, England.

The launch of the ACT NOW Coalition has set the goal of ending the AIDS epidemic in New York by 2020, and hopes collaboration will urge the same across the country.

"The is no one living with HIV in this country who shouldn't have access to a treatment combination that works for them."

From showgirls to scientists, attendees at the 20th Annual US Conference on AIDS found much to celebrate and a lot left to be done in the quest to conquer HIV/AIDS.

According to Charles King, President and CEO of Housing Works, "It really doesn't matter what part of the world you're in. If you're having to struggle with issues around sexism, racism, homophobia, transphobia, homelessness, addiction, mental illness, they are all drivers of very bad health outcomes for people - whether you're talking about HIV, hepatitis C, or tuberculosis."

David Ho, MD, has been a pioneer in the development of AIDS antivirals, starting with his work on protease inhibitors 20 years ago. Kicking off the US Conference on AIDS today in Hollywood, FL, Ho said a new bi-monthly injection is looking like the next breakthrough in HIV/AIDS prevention.

Tuberculosis (TB) is of particular concern for patients with the human immunodeficiency virus (HIV), as it’s a leading cause of death in people with HIV worldwide.

Dormant viruses dodge the immune system, and although these viruses don’t actively replicate, the problem is that they also don’t produce a chemical signal which would tell the antiretroviral therapy (ART) to attack them.

Adverse side effects are a potential risk with nearly every medication, so scientists from the University of Oxford in England looked at if this phenomenon occurs in common drugs that are used to treat the human immunodeficiency virus (HIV).

People with the human immunodeficiency virus (HIV) who are also depressed have a 30% increased risk for acute myocardial infraction (AMI) when compared to non-depressed people with HIV.

There are groups of people who are more likely to become infected with the human immunodeficiency virus (HIV) and, therefore, should be taking pre-exposure prophylaxis (PrEP). But are high-risk, HIV-negative people actually taking the preventive medication?